Poly Medicure Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Poly Medicure Limited generated cash of $2,660,822,000, which is more than the previous year. Cash used in financing activities reached the amount of -$201,535,000 last year. Net change in cash is therefore $49,907,000.
Cash Flow
| 2010 | 212.56M | -119.67M | -89.62M |
|---|---|---|---|
| 2011 | 234.74M | -236.85M | 3.07M |
| 2012 | 330.18M | -263.93M | -65.57M |
| 2016 | 633.94M | -313.77M | -309.62M |
| 2018 | 749.27M | -880.01M | 157.13M |
| 2020 | 1.30B | -1.09B | -205.06M |
| 2021 | 1.18B | -4.35B | 3.16B |
| 2023 | 1.90B | -1.79B | -125.05M |
| 2024 | 2.66B | -2.40B | -201.53M |
POLYMED.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 70.62M | 77.57M | 48.57M | 43.17M | 10.60M | 118.55M | 5.06M | 11.12M | 7.86M |
Operating activities | |||||||||
Net income | 2.58B | 2.37B | 1.80B | 1.23B | 955.11M | 650.41M | 194.69M | 216.71M | 157.99M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 639.26M | 571.66M | 475.22M | 405.27M | 292.44M | 210.28M | 117.40M | 94.23M | 78.32M |
Stock-based compensation expense | 0 | 19.27M | 6.47M | 1.38M | 1.80M | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 19.27M | 6.47M | 1.38M | 1.80M | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -366.85M | -287.96M | -332.29M | 58.99M | -151.38M | -205.78M | 0 | 0 | 0 |
Inventories | -123.75M | -402.90M | -143.87M | -283.04M | -110.42M | 116.22M | -48.32M | -35.15M | -73.50M |
Accounts payable | 37.61M | 37.69M | 595K | 102.02M | 16.61M | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 2.66B | 1.90B | 1.18B | 1.30B | 749.27M | 633.94M | 330.18M | 234.74M | 212.56M |
Investing activities | |||||||||
Purchases Of Investments | 0 | -579.11M | -3.44B | -172.00M | -122.74M | -7.84M | -40K | 0 | 0 |
Investments In Property Plant And Equipment | -2.77B | -2.39B | -951.31M | -1.06B | -824.56M | -326.19M | -269.27M | -238.61M | -120.72M |
Acquisitions Net | 0 | 1.47M | 6.14M | 68.17M | 2.45M | 803K | 0 | 0 | 0 |
Cash generated by investing activities | -2.40B | -1.79B | -4.35B | -1.09B | -880.01M | -313.77M | -263.93M | -236.85M | -119.67M |
Financing activities | |||||||||
Common Stock Issued | 2.63M | 3.51M | 4B | 503K | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -287.4M | -239.73M | 0 | -424.74M | -53.09M | -265.46M | -33.03M | -27.15M | -13.71M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 211.19M | 209.89M | -664.51M | 332.94M | 309.30M | 39.24M | 0 | 0 | 0 |
Cash used in financing activities | -201.53M | -125.05M | 3.16B | -205.06M | 157.13M | -309.62M | -65.57M | 3.07M | -89.62M |
Net Change In Cash | 49.90M | -6.95M | 972K | 5.39M | 26.39M | 10.55M | 678K | 972K | 3.26M |
Cash at end of period | 120.53M | 70.62M | 49.54M | 48.57M | 37.00M | 129.10M | 5.73M | 12.09M | 11.12M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |